These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27889505)

  • 1. Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats.
    Khuman MW; Harikumar SK; Sadam A; Kesavan M; Susanth VS; Parida S; Singh KP; Sarkar SN
    Toxicology; 2016 Dec; 374():29-41. PubMed ID: 27889505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic causes aortic dysfunction and systemic hypertension in rats: Augmentation of angiotensin II signaling.
    Waghe P; Sarath TS; Gupta P; Kandasamy K; Choudhury S; Kutty HS; Mishra SK; Sarkar SN
    Chem Biol Interact; 2015 Jul; 237():104-14. PubMed ID: 26079204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qingxuan Jiangya Decoction () Prevents Blood Pressure Elevation and Ameliorates Vascular Structural Remodeling via Modulating TGF-β 1/Smad Pathway in Spontaneously Hypertensive Rats.
    He F; Chu JF; Chen HW; Lin W; Lin S; Chen YQ; Peng J; Chen KJ
    Chin J Integr Med; 2020 Mar; 26(3):180-187. PubMed ID: 31883057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan.
    Cervenka L; Navar LG
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S197-201. PubMed ID: 9892163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats.
    Sarath TS; Waghe P; Gupta P; Choudhury S; Kannan K; Pillai AH; Harikumar SK; Mishra SK; Sarkar SN
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):443-54. PubMed ID: 25218292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats.
    Wang Y; Wang L; Zhang F; Zhang C; Deng S; Wang R; Zhang Y; Huang D; Huang K
    Int J Cardiol; 2013 Sep; 167(5):2285-93. PubMed ID: 22846599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic attenuation of myocardial fibrosis in spontaneously hypertensive rats by joint treatment with benazepril and candesartan.
    Meng G; Wu F; Yang L; Zhu H; Gu J; He M; Xu J
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):16-24. PubMed ID: 19487956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
    Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
    Inscho EW; Imig JD; Deichmann PC; Cook AK
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S178-83. PubMed ID: 9892160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan inhibited angiotensin II-induced collagen metabolic imbalance without directly targeting TGF-β 1/Smad signaling pathway in cardiac fibroblasts.
    Zhang Y; Zhao NA; Wang JK; Zhu SM; Zhu HL; Liu B; Cui QW; Guan GC; Tian G
    Minerva Cardioangiol; 2015 Dec; 63(6):507-14. PubMed ID: 26657532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats.
    Nagai M; Horikoshi K; Izumi T; Seki S; Taniguchi M; Taniguchi I; Mochizuki S
    Cardiovasc Drugs Ther; 2004 Sep; 18(5):353-62. PubMed ID: 15717137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-depressor dose of angiotensin type-1 receptor blocker inhibits transforming growth factor-beta-mediated perivascular fibrosis in hypertensive rat hearts.
    Tokuda K; Kai H; Kuwahara F; Imaizumi T
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S61-5. PubMed ID: 14871031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenite Induces Vascular Endothelial Cell Dysfunction by Activating IRE1α/XBP1s/HIF1α-Dependent ANGII Signaling.
    Xu X; Liu S; Aodengqimuge ; Wang H; Hu M; Xing C; Song L
    Toxicol Sci; 2017 Dec; 160(2):315-328. PubMed ID: 28973481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.
    Tokuda K; Kai H; Kuwahara F; Yasukawa H; Tahara N; Kudo H; Takemiya K; Koga M; Yamamoto T; Imaizumi T
    Hypertension; 2004 Feb; 43(2):499-503. PubMed ID: 14699000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist.
    Otsuka M; Takahashi H; Shiratori M; Chiba H; Abe S
    Thorax; 2004 Jan; 59(1):31-8. PubMed ID: 14694243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
    Ueki M; Koda M; Yamamoto S; Matsunaga Y; Murawaki Y
    J Gastroenterol; 2006 Oct; 41(10):996-1004. PubMed ID: 17096069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
    de Boer RA; Pokharel S; Flesch M; van Kampen DA; Suurmeijer AJ; Boomsma F; van Gilst WH; van Veldhuisen DJ; Pinto YM
    J Mol Med (Berl); 2004 Oct; 82(10):678-87. PubMed ID: 15322702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.